证券代码：002326 证券简称：永太科技 公告编号：2023-061 浙江永太科技股份有限公司 2023 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、本次股东大会召开期间没有否决议案的情况发生。 2、本次股东大会不涉及变更前次股东大会决议的情况。 3、会议召开方式：现场会议与网络投票相结合的方式。 4、会议召集人：公司董事会。 5、会议主持人：本次会议由董事长王莺妹女士主持。 一、会议召开和出席情况 （一）会议召开情况 1、召开时间 （1）现场召开时间：2023 年 9 月 20 日（星期三）14:30； （2）网络投票时间：2023 年 9 月 20 日； 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2023 年 9 月 20 日 9:15 至 9:25，9:30 至 11:30, 13:00 至 15:00； 通过深圳证券交易所互联网投票的具体时间为 2023 年 9 月 20 日 9:15 至 15:00 期间的任意时间。 2、现场会议召开地点：浙江省化学原料药基地临海园区东海第四大道 1 ...

证券代码：002326 证券简称：永太科技 公告编号：2023-060 浙江永太科技股份有限公司 | | | | 本次质押及 | 本次质押及 | 占其所 | 占公司 | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 持股数量 | 持股比 | 解除质押前 | 解除质押后 | 持股份 | 总股本 | 已质押股份限 | 占已质 | 未质押股份 | 占未质 | | 名称 | （万股） | 例（%） | 质押股份数 | 质押股份数 | 比例（%） | 比例 | 售和冻结数量 | 押股份 | 限售和冻结 | 押股份 | | | | | 量（万股） | 量（万股） | | （%） | （万股） | 比例（%） | 数量（万股） | 比例（%） | | 王莺妹 | 14,424.84 | 15.79 | 4,915.80 | 5,865.80 | 40.66 | 6.42 | 5,865.80 | 100.00 | 4,952.83 | 57.87 | | 何人宝 | 11, ...

Financial Performance - Total operating revenue for the first half of 2023 was ¥2,053,255,250.17, a decrease of 38.1% compared to ¥3,316,898,537.85 in the same period of 2022[25] - The net comprehensive income attributable to the parent company was ¥29,703,057.57, down from ¥496,366,696.10 in the previous year[27] - Basic and diluted earnings per share for the first half of 2023 were both ¥0.04, compared to ¥0.56 in the same period of 2022[27] - The company reported a significant decrease in comprehensive income, totaling ¥4,209,590.20 for the first half of 2023, compared to ¥566,755,028.84 in the same period of 2022[27] - The company's operating revenue for the first half of 2023 was ¥735.65 million, a decrease of 33.2% compared to ¥1,101.85 million in the same period of 2022[55] - Operating profit for the first half of 2023 was ¥109.98 million, down 14.4% from ¥128.56 million in the first half of 2022[56] - The net profit for the first half of 2023 increased to ¥113.16 million, up 9.9% from ¥103.06 million in the same period of 2022[56] - The total comprehensive income for the first half of 2023 is approximately 113.16 million RMB[67] Cash Flow and Investments - The net cash outflow from operating activities was CNY 202.5 million, a significant decrease from a net inflow of CNY 467.4 million in the same period last year, representing a decline of approximately 143.3%[30] - Cash inflow from investment activities totaled CNY 133.5 million, down from CNY 198.2 million in the previous year, reflecting a decrease of about 32.6%[30] - The net cash outflow from investment activities was CNY 170.6 million, an improvement compared to a net outflow of CNY 450.0 million in the same period last year, indicating a reduction of approximately 62.0%[30] - Cash inflow from financing activities increased to CNY 1.98 billion, compared to CNY 1.34 billion in the previous year, marking a growth of approximately 47.8%[30] - The net cash flow from financing activities was CNY 434.2 million, a significant increase from CNY 123.8 million in the same period last year, representing a growth of about 250.0%[30] - The total cash and cash equivalents at the end of the period amounted to CNY 493.5 million, a decrease from CNY 522.1 million at the end of the previous year, reflecting a decline of approximately 5.5%[30] - The company reported cash inflow from financing activities of ¥1,221.73 million, an increase of 26.0% from ¥968.95 million in the same period of 2022[59] Shareholder Information - The total number of shares outstanding as of the report date was 876,566,295, with 12.52% being restricted shares[11] - The company experienced a reduction of 119,522,234 restricted shares, resulting in a new total of 109,727,860 restricted shares[11] - The number of shareholders holding more than 5% of ordinary shares was 143,409 as of the report date[14] - As of June 30, 2023, the total issued share capital of the company is 876,566,295 shares, with a registered capital of 876,566,295 yuan[41] - The company has a total share capital of 876.57 million RMB as of June 30, 2023[67] Assets and Liabilities - The company's total assets as of June 30, 2023, amount to 4,300,161,402.20 yuan, a decrease from 4,468,216,615.57 yuan at the beginning of the year[49] - The company's inventory as of June 30, 2023, is 1,722,688,867.75 yuan, an increase from 1,656,002,531.68 yuan at the beginning of the year, reflecting a growth of approximately 4.0%[49] - The company's cash and cash equivalents as of June 30, 2023, are 913,836,684.15 yuan, down from 959,294,353.56 yuan at the beginning of the year, indicating a decrease of about 4.7%[49] - The company's accounts receivable as of June 30, 2023, stand at 911,323,787.80 yuan, down from 1,097,584,586.54 yuan at the beginning of the year, representing a decline of approximately 17.0%[49] Research and Development - Research and development expenses increased to ¥42.91 million, up 29.5% from ¥33.14 million in the first half of 2022[55] Compliance and Governance - The company did not report any major related party transactions during the reporting period[1] - The company has not undergone any changes in its actual controller during the reporting period[45] - The company has not issued any preferred shares during the reporting period[46] - The company has not engaged in any repurchase transactions by its top shareholders during the reporting period[43] - The financial report is guaranteed to be true, accurate, and complete by the company's responsible personnel[195] - The company has disclosed all original documents and announcements during the reporting period[199] Accounting Policies - The financial statements are presented in RMB, adhering to the enterprise accounting standards[77] - The financial statements were prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring a true and complete reflection of the company's financial status as of June 30, 2023[96] - The company applies specific accounting policies for bad debt provisions, fixed asset depreciation, and revenue recognition based on its operational characteristics[95] - The company recognizes goodwill when the acquisition cost exceeds the fair value of identifiable net assets acquired in a business combination[99] - The company ensures that internal transactions between itself and subsidiaries are eliminated in the consolidated financial statements[101] - The company has established a financial asset classification system based on its business model and cash flow characteristics[107] - The company’s financial reporting adheres to the guidelines set forth by the China Securities Regulatory Commission, ensuring compliance with disclosure requirements[92] Future Plans - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves[196]

证券代码：002326 证券简称：永太科技 公告编号：2023-054 浙江永太科技股份有限公司 关于控股股东部分股权质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江永太科技股份有限公司（以下简称"公司"）近日接到控股股东何人宝 先生的通知，获悉何人宝先生所持有本公司的部分股权进行了质押。具体事项如 下： 一、股东股份本次质押基本情况 | 股东 | 是否为第一 大股东及一 | | 本次质押数 | 占其所持股 | 占公司总股 | 是否为 | 是否为补 | 质押 | 质押 | 质权人 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | | | 量（万股） | 份比例(%) | 本比例(%) | 限售股 | 充质押 | 开始日 | 到期日 | | 用途 | | | 致行动人 | | | | | | | | | | | | 何人宝 | | 是 | 90.60 | 0.81 | 0.10 | 否 | 是 | 2023-08-15 | ...

浙江永太科技股份有限公司投资者关系活动 记录表 编号：2023-04 | --- | --- | --- | |----------------------|----------------------------------|--------------------------------------------------| | | | | | | 特定对象调研 | 分析师会议 | | 投资者关系活动类别 | 媒体采访 | 业绩说明会 | | | 新闻发布会 | 路演活动 | | | 现场参观 | 其他 | | 活动参与人员 | 公司董事长：王莺妹 | | | | 独立董事：许永斌 | | | | 董事、副总经理、财务总监：陈丽洁 | | | | 董事会秘书、副总经理：张江山 | | | | 通过全景网"投资者关系互动平台"（ | https://ir.p5w.net ） | | | 参与业绩说明会的投资者 | | | | | | | 时间 | 2023 年 5 月 5 日 | （周五） 15:00-17:00 | | | | | | 地点 | 网络平台 | | | 形式 | 线上交流 | | | | | ...

Financial Performance - The company reported a 42.10% year-over-year decline in operating revenue, totaling approximately ¥1,005.91 million for the first quarter of 2023, compared to ¥1,737.30 million in the same period last year[14]. - Net profit attributable to shareholders decreased by 93.51% year-over-year, amounting to approximately ¥43.42 million, down from ¥517.37 million in the previous year[14]. - The net profit excluding non-recurring items fell by 97.49% year-over-year, indicating significant operational challenges during the reporting period[6]. - The company's overall gross margin and gross profit for the reporting period were 24.81% and 249.55 million yuan, respectively, down significantly from 40.26% and 699.48 million yuan in the same period last year[19]. - Operating revenue decreased by 42.10% due to a decline in sales of lithium battery and trading products[21]. - Net profit decreased by 96.10%, attributed to the decline in gross margin leading to reduced profits[21]. - The basic earnings per share for Q1 2023 was ¥0.029, down 93.48% from ¥0.445 in the same period last year[59]. - The weighted average return on equity decreased to 0.74%, down 9.76 percentage points from 10.50% year-on-year[59]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 57.35% due to reduced sales collections and increased material payments[39]. - The company's cash and cash equivalents at the end of the reporting period were approximately 881.40 million yuan, down from 959.29 million yuan at the beginning of the year[25]. - Total operating cash inflow for Q1 2023 was CNY 1,074,971,411.23, a decrease of 22.5% compared to CNY 1,387,970,763.24 in the same period last year[104]. - Net cash generated from operating activities was CNY 151,094,627.53, down 57.4% from CNY 354,261,293.85 in Q1 2022[104]. - Cash received from other operating activities was CNY 33,549,224.61, a decline from CNY 42,238,538.56 year-over-year[104]. - Total cash outflow from operating activities was CNY 923,876,783.70, compared to CNY 1,033,709,469.39 in the same quarter last year[104]. - Cash received from investment recovery was CNY 35,000,000.00, significantly lower than CNY 123,289,057.14 in Q1 2022[104]. - Cash paid for investments was CNY 25,000,000.00, up from CNY 19,000,000.00 in the previous year[104]. Assets and Liabilities - The company's total assets increased to approximately ¥11.58 billion, up from ¥11.35 billion at the beginning of the year, reflecting a growth of 2.01%[13]. - The total liabilities of the company increased to approximately 7.82 billion yuan from 7.61 billion yuan at the beginning of the year[44]. - The total liabilities and shareholders' equity amounted to approximately ¥11.58 billion, indicating a stable financial position despite the operational downturn[13]. - Long-term borrowings rose by 41.84% to approximately ¥3.16 billion, attributed to increased bank loans during the reporting period[7]. Investments and Subsidiaries - The company established a joint venture, Zhejiang Yongtai Fluorine Technology Co., Ltd., with an investment of ¥96 million, representing an 80% stake[10]. - A wholly-owned subsidiary, Shandong Yonghong Lithium Technology Co., Ltd., was established with an investment of ¥100 million to support future business development[10]. - The company plans to establish a joint venture, Fujian Yongtai Fluorine Source Technology Co., Ltd., with an investment of ¥97.5 million, representing a 65% stake[81]. Research and Development - Research and development expenses for the quarter were approximately ¥35.54 million, slightly up from ¥34.25 million in the previous year, indicating continued investment in innovation[14]. Financial Management - The company reported a significant increase in special reserves by 86.41%, reflecting proactive financial management strategies[7]. - Financial expenses increased by 35.98% due to increased exchange losses during the reporting period[21]. - The company received government subsidies, leading to a 2464.55% increase in other income[21]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 153,302[22]. - The company reported a net increase in cash and cash equivalents of ¥7,896,831.42 for Q1 2023, compared to an increase of ¥45,934,874.80 in the same period last year[55].

Financial Performance - In 2022, the company's total operating revenue was approximately CNY 6.83 billion, with quarterly revenues of CNY 1.74 billion, CNY 1.58 billion, CNY 1.56 billion, and CNY 1.45 billion respectively[6]. - The net profit attributable to shareholders for the year was CNY 553 million, with quarterly profits of CNY 389.78 million, CNY 103.82 million, CNY 58.14 million, and CNY 2.18 million[6]. - The company reported a total profit of CNY 798,571,420.91 for 2022, which is an increase from CNY 439,367,449.73 in 2021, reflecting a growth of around 81.9%[153]. - The net profit for 2022 was CNY 659,609,481.40, compared to CNY 332,214,636.86 in 2021, marking an increase of about 98.3%[153]. - The total comprehensive income for 2022 was CNY 658,901,605.32, up from CNY 330,419,308.68 in 2021, indicating an increase of approximately 99.5%[153]. Cost and Expenses - The gross margin for the lithium battery materials segment was 41.60%, but the overall gross margin for the company decreased to 28.07% in Q4 due to falling product prices and rising raw material costs[7]. - The total expenses (taxes, sales, management, R&D, and financial costs) increased by 7.21% year-on-year, amounting to CNY 1 billion, which accounted for 15.79% of total revenue, a decrease of 5.09 percentage points from the previous year[7]. - Operating costs for 2022 amounted to ¥5,450,837,949.34, up from ¥3,867,245,334.10 in 2021, reflecting a 41% increase[113]. - The pharmaceutical segment's total costs reached ¥907,423,388.22, accounting for 34.23% of total operating costs, with a year-on-year increase of 28.86% from ¥704,174,263.13[144]. Research and Development - The company recorded a significant increase in R&D expenses, which rose by 37.71% year-on-year to CNY 17.42 million, reflecting a focus on innovation and product development[7]. - Research and development expenses rose to ¥174,210,673.30 in 2022, compared to ¥126,505,011.60 in 2021, indicating a 38% increase[113]. - The company applied for a total of 186 invention patents, with 145 patents granted[131]. - The company is focusing on enhancing its competitive edge through technological innovation and cost control measures[126]. Cash Flow and Financial Position - The company faced a net cash flow from operating activities of CNY 204.28 million in Q3, but reported a negative cash flow of CNY -448.04 million in Q4, indicating cash management challenges[6]. - The cash flow from operating activities was CNY 4,703,668,494.43 in 2022, compared to CNY 2,966,539,406.55 in 2021, reflecting an increase of approximately 58.5%[154]. - The company's total assets increased to CNY 11,354,490,240.65 as of December 31, 2022, from CNY 9,724,424,738.20 on January 1, 2022, representing a growth of approximately 16.77%[104]. - The company's total liabilities reached CNY 7,608,701,914.88 as of December 31, 2022, compared to CNY 5,989,766,706.20 at the start of the year, marking an increase of around 27.03%[102]. Market Trends and Strategic Initiatives - The company plans to enhance its market expansion efforts and product development in response to changing market demands and competitive pressures[7]. - The company is accelerating its layout and capacity expansion in lithium battery materials to enhance its competitiveness in the new energy materials sector[16]. - The pharmaceutical industry is transitioning from rapid growth to high-quality development, driven by increasing demand for drugs and medical services due to an aging population and rising income levels[17]. - The company aims to deepen its vertical integration in the pharmaceutical sector, focusing on intermediates, active pharmaceutical ingredients, and formulations, while expanding into international markets[17]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 156,802, indicating a broad shareholder base[26]. - Major shareholders include Wang Yingmei with a 16.46% stake and He Renbao with a 12.71% stake, both of whom have pledged a portion of their shares[26]. - The company has not engaged in any repurchase transactions during the reporting period, reflecting a stable capital structure[35]. Production Capacity and Operations - The company has established a vertically integrated industrial chain in both pharmaceutical and lithium battery materials, improving operational efficiency and cost advantages[76]. - The production capacity for lithium battery materials is 16,990.00 tons/year with a utilization rate of 63.78% and 204,500.00 tons/year of capacity under construction[69]. - The company is constructing a project for an annual production of 67,000 tons of lithium hexafluorophosphate, which received environmental approval in February 2023[72]. - The company operates a flexible comprehensive production platform and a professional R&D innovation team, providing customized R&D, production, and technical services to domestic and international clients[19].

网上业绩说明会的通知 证券代码：002326 证券简称：永太科技 公告编码：2023-026 浙江永太科技股份有限公司 关于举行 2022 年度暨 2023 年第一季度 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、 误导性陈述或者重大遗漏。 浙江永太科技股份有限公司（以下简称"公司"）将于2023年5月5日（星期 五）15:00—17:00在全景网举办2022年度暨2023年第一季度业绩说明会，本次业 绩说明会将采用网络远程的方式举行，投资者可登录"全景•路演天下" （http://rs.p5w.net）参与本次说明会。 出席本次说明会的人员有：公司董事长王莺妹女士，独立董事许永斌先生， 董事、副总经理、财务总监陈丽洁女士，董事会秘书、副总经理张江山先生。 为充分尊重投资者、提升交流的针对性，现就公司2022年度暨2023年第一季 度网上业绩说明会提前向投资者公开征集问题，广泛听取投资者的意见和建议。 投资者可于2023年5月4日15:00前访问http://ir.p5w.net/zj/，或扫描下方二维 码，进入问题征集专题页面。公司将在业绩说明会上，对投资者普遍关注的问题 进行回答。 ...

浙江永太科技股份有限公司投资者关系活动记录表 证券代码：002326 证券简称：永太科技 编号：20140702 | --- | --- | --- | |-------------------------|----------------------------------------|---------------------------------------------------------------| | | 特定对象调研 分析师会议 | | | 投资者关系活动 | 媒体采访 | 业绩说明会 | | 类别 | 新闻发布会 | 路演活动 | | | 现场参观 其他 | | | 参与单位名称及 人员姓名 | 上海万丰友方投资管理有限公司 | 张荣福 | | 时间 2014 年 7 月 2 | | 日上午 8:30 | | 地点 公司总部 | | | | 上市公司接待人 | 董事会秘书 关辉 | | | 员姓名 | 证券部经理 戴涛 | | | | 1.公司 2014 年一季度业绩情况如何？ | | | | 2014 年一季度公司实现营业收入 | 178,172,492.10 元，比上年同期增长 | ...

浙江永太科技股份有限公司投资者关系活动记录表 证券代码：002326 证券简称：永太科技 编号：20140710 | --- | --- | --- | |-----------------------------|---------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...